The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 22nd Oct 2020 16:01

Friday 23 October 
Essentra PLCThird Quarter Results
Barclays PLCThird Quarter Results
London Stock Exchange Group PLCThird Quarter Results
InterContinental Hotels Group PLCThird Quarter Results
Airtel Africa PLCHalf Year Results
Avation PLCFull Year Results
Monday 26 October 
THG Holdings PLCThird Quarter Results
Tuesday 27 October 
Bloomsbury Publishing PLCHalf Year Results
Plus500 LtdThird Quarter Results
St James's Place PLCThird Quarter Results
HSBC Holdings PLCThird Quarter Results (at 0400 GMT)
Dechra Pharmaceuticals PLCTrading Statement
Whitbread PLCHalf Year Results
Shoe Zone PLCTrading Statement
BP PLCThird Quarter Results
Hunting PLCTrading Statement
First Derivatives PLCHalf Year Results
Renalytix AI PLCFull Year Results
ContourGlobal Group PLCTrading Statement
Wednesday 28 October 
John Laing Group PLCTrading Statement
Ibstock PLCTrading Statement
Gem Diamonds LtdTrading Statement
Elementis PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
GlaxoSmithKline PLCThird Quarter Results (at midday)
Next PLCTrading Statement
Bank of Ireland Group PLCTrading Statement
Omega Diagnostics Group PLCTrading Statement
Itaconix PLCHalf Year Results
Thursday 29 October 
Royal Dutch Shell PLCThird Quarter Results
Angle PLCHalf Year Results
Standard Chartered PLCThird Quarter Results (at 0415 GMT)
WPP PLCTrading Statement
Helios Towers PLCThird Quarter Results
Smith & Nephew PLCTrading Statement
Lloyds Banking Group PLCThird Quarter Results
Travis Perkins PLCTrading Statement
KAZ Minerals PLCThird Quarter Production
BT Group PLCHalf Year Results
International Personal Finance PLCTrading Statement
Indivior PLCThird Quarter Results
Glanbia plcThird Quarter Results
Foxtons Group PLCTrading Statement
Evraz PLCTrading Statement
Smith & Nephew PLCThird Quarter Trading Statement
Proactis Holdings PLCFull Year Results
Hilton Food Group PLCTrading Statement
Verona Pharma PLCThird Quarter Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Mar 2019 11:28

DIRECTOR DEALINGS: Verona Pharma Chair David Ebsworth Buys Shares

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Verona Pharma PLC said on Thursday Chair David Ebsworth bought 26,300 shares for 56.30 pence each on Wednesday.Following in

Read more
4 Mar 2019 13:35

Monday broker round-up

(Sharecast News) - RSA Insurance Group: JP Morgan downgrades to neutral with a target price of 610p.

Read more
4 Mar 2019 10:12

Verona Pharma Reports Positive Data From Lung Disease Treatment Trial

LONDON (Alliance News) - Shares in Verona Pharma PLC rose on Monday following positive data from part of a Phase Two clinical trial of a dry powder inhaler formulation of Verona's ensifentrine

Read more
14 Jan 2019 10:23

WINNERS & LOSERS SUMMARY: JD Sports Rises After Strong Christmas

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - LOSERS----------Paddy Power

Read more
14 Jan 2019 09:47

Verona Pharma's Ensifentrine COPD Study Does Not Meet Primary Endpoint

LONDON (Alliance News) - Verona Pharma PLC on Monday said its phase two clinical trial of nebulized Ensifentrine did not meet its primary endpoint but did perform better than placebo.Shares

Read more
14 Jan 2019 08:48

Verona Pharma shares plunge on latest drug trial results

(Sharecast News) - Verona Pharma shares were well into the red on Monday, after the clinical-stage biopharmaceutical company announced top-line data from its latest trial of RPL554, failing to reach its primary endpoint.

Read more
9 Jan 2019 15:44

Verona Pharma granted WHO approval for Ensifentrine name

(Sharecast News) - Clinical stage biopharmaceutical outfit Verona Pharma has been granted approval of the name Ensifentrine for its first-in-class, inhaled, dual inhibitor drug candidate RPL554 by the World Health Organisation.

Read more
17 Dec 2018 14:22

Verona Pharma initiates Phase 2 study of RPL554

(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma announced the initiation of a Phase 2 clinical trial to evaluate the pharmacokinetic (PK) profile, efficacy and safety of a dry powder inhaler (DPI) formulation of 'RPL554', in patients with moderate to severe chronic obstructive pulmonary disease (COPD), on Monday.

Read more
6 Nov 2018 11:56

Verona Pharma Third-Quarter Loss Narrows On Finance Income

LONDON (Alliance News) - Verona Pharma PLC on Tuesday said its loss narrowed by two thirds in the third quarter of 2018 on increased finance income and reduced costs as it initiated a phase two of

Read more
31 Oct 2018 12:25

Verona Pharma Completes Enrollment In Clinical Trial Of RPL554

LONDON (Alliance News) - Verona Pharma PLC said Wednesday it has completed the enrollment for its Phase 2 clinical trial evaluating the effect of nebulised RPL554 as an add-on to dual therapy in a

Read more
26 Oct 2018 11:46

Verona Pharma turns in positive data from RPL554 trials

(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma turned in some positive data from its pre-clinical and Phase 2a trials on its potential cystic fibrosis treatment RPL554.

Read more
1 Aug 2018 12:49

Verona Pharma Starts Phase 2 Trial For Respiratory Disease Treatment

LONDON (Alliance News) - Verona Pharma PLC said Wednesday that it started the second phase of a clinical trial of its nebulized RPL554 drug for the treatment of patients with chronic obstructive 2

Read more
8 May 2018 07:01

LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a faster pace in April amid concerns the US

Read more
26 Mar 2018 10:19

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

LONDON (Alliance News) - Verona Pharma PLC said Monday it has received positive top-line data from its phase 2b study for its proposed RPL554 treatment.RPL554 is a for

Read more
8 Mar 2018 13:59

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

LONDON (Alliance News) - Verona Pharma PLC, a clinical-stage biopharmaceutical company, said Thursday that Chief Executive Officer Jan-Anders Karlsson purchased 3,250 ordinary

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.